In a 50-year-old woman with acute confusion, abnormal eye movements, acute kidney injury, isolated thrombocytopenia, and a negative lumbar puncture, what is the differential diagnosis?

Thrombotic Thrombocytopenic Purpura (TTP) is the most likely diagnosis and must be treated immediately

This 50-year-old woman with confusion, abnormal eye movements, AKI, and isolated thrombocytopenia has TTP until proven otherwise, and you must start plasma exchange, corticosteroids, and caplacizumab immediately before ADAMTS13 results return 1.

Why TTP is the Primary Diagnosis

The clinical constellation is classic for TTP despite the absence of the full pentad (which occurs in <5% of cases) 1:

• Neurological involvement (confusion + abnormal eye movements) is the second most common TTP manifestation and strongly suggests this diagnosis when combined with thrombocytopenia 1
• Mild-to-moderate AKI is typical for TTP, distinguishing it from other thrombotic microangiopathies that cause severe renal dysfunction 1
• Female sex at age 50 fits the demographic (female-to-male ratio 2.5-3.5:1 for immune TTP) 1
• Negative LP excludes infectious/inflammatory CNS processes, redirecting focus to thrombotic microangiopathy

Critical Immediate Actions

Before any confirmatory testing:

1. Draw blood for ADAMTS13 activity (must be <10% to confirm TTP) 1
2. Check peripheral smear for schistocytes (may be initially absent but indicates microangiopathic hemolytic anemia) 1
3. Verify hemolysis markers: elevated LDH, indirect bilirubin, low haptoglobin, negative direct Coombs test 1
4. Start treatment immediately - do not wait for ADAMTS13 results 1

Complete Differential Diagnosis

Primary Considerations (Thrombotic Microangiopathies):

1. Thrombotic Thrombocytopenic Purpura (TTP) - Most likely

• Neurological symptoms fluctuate in severity and location 1
• Eye movement abnormalities represent focal neurological deficits
• Kidney dysfunction typically mild-to-moderate 1
• Requires ADAMTS13 activity <10% for confirmation 1

2. Atypical Hemolytic Uremic Syndrome (aHUS)

• Can present with neuropsychiatric symptoms 2
• Usually causes more severe AKI than TTP 1
• Check complement levels (C3, C4) - persistently low C3 suggests complement activation 3
• Consider if ADAMTS13 activity >10%

3. Complement-mediated HUS

• May show moderate ADAMTS13 deficiency (not severe) 1
• More prominent renal failure than TTP
• Requires complement testing

Secondary Considerations:

4. Hypertensive Emergency with TMA

• Check blood pressure urgently 4
• HTN-TMA can cause identical presentation
• Thrombocytopenia and anemia improve with BP control alone 4

5. Systemic Lupus Erythematosus with Catastrophic Antiphospholipid Syndrome

• Can cause multiorgan ischemia with thrombocytopenia 5
• Check ANA, anti-dsDNA, antiphospholipid antibodies
• May have non-inhibitory anti-ADAMTS13 antibodies causing secondary TTP 5

6. Drug-Induced TMA

• Recent medication exposure? 3
• Certain drugs can trigger HUS-like syndrome

Less Likely (but exclude):

7. Uremic Encephalopathy

• AKI alone can cause confusion 6
• Does NOT explain thrombocytopenia
• Does NOT cause abnormal eye movements typically
• Diagnosis of exclusion

8. Sepsis with DIC

• Would expect abnormal coagulation profile (PT/PTT elevated, low fibrinogen)
• TTP has normal coagulation studies 1

Diagnostic Algorithm

Step 1: Confirm Thrombotic Microangiopathy

• Peripheral smear: schistocytes present?
• Hemolysis markers: elevated LDH, indirect bilirubin, low haptoglobin?
• Direct Coombs: should be negative in TTP 1

Step 2: Distinguish TTP from Other TMAs

• ADAMTS13 activity <10% = TTP confirmed (97% sensitivity, 100% specificity) 1
• ADAMTS13 10-50% = consider complement-mediated HUS, sepsis, autoimmunity 1
• Normal coagulation profile favors TTP over DIC 1

Step 3: Identify Secondary Causes

• Blood pressure measurement (hypertensive emergency?)
• Autoimmune workup: ANA, complement levels, antiphospholipid antibodies
• Pregnancy test (mandatory in all women) 1
• Medication review

Critical Pitfalls to Avoid

1. Waiting for ADAMTS13 results before starting treatment - This is the most dangerous error. Organ damage is reversible if treated early 1

2. Assuming normal brain imaging excludes TTP - MRI is normal in >50% of TTP cases 1

3. Dismissing TTP because thrombocytopenia is not severe - While typically <30×10⁹/L, higher counts don't rule out TTP 1

4. Attributing confusion solely to uremia - The combination with abnormal eye movements and thrombocytopenia demands TMA evaluation

5. Stopping at "negative LP" - This excludes infection but doesn't address the vascular/hematologic process

Immediate Management Priority

Start empiric TTP treatment now with plasma exchange, corticosteroids, and caplacizumab while awaiting ADAMTS13 results 1. The organ damage in TTP is largely reversible with early treatment, and usual critical care outcome predictors don't apply 1. Delaying treatment to confirm diagnosis increases mortality and morbidity significantly.